Summary
Sevion Therapeutics, Inc. (Sevion) formerly Senesco Technologies, Inc is a cancer therapeutic company that discovers, develops and acquires innovative product candidates for the treatment of cancer and immunological diseases. The company’s offer products in autoimmune disease, oncology, diabetes, pain. It offers various pipelines such as Antibody Pipeline, Chimerasome Pipeline and Gene Regulation Pipeline. Sevion offers products and technologies in the areas of eIF5A, cancer, and inflammation. The company also concentrates on cancer, multiple myeloma (MM) and other B-cell cancers including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL). Sevion is headquartered in San Diego, California, the US
Sevion Therapeutics, Inc. (SVON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sevion Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Fabrus Secures US$2 Million In Venture Financing 12
Partnerships 13
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 13
Sevion Therapeutics to Form Joint Venture with Malvern Instruments 14
Sevion Therapeutics Enters into Discovery Agreement with CNA Development 15
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 16
Fabrus Enters Into Research Agreement With Ambrx 17
Licensing Agreements 18
Fabrus Enters into Licensing Agreement with Scripps Research Institute 18
Equity Offering 19
Sevion Therapeutics Raises USD6.6 Million in Private Placement of Units 19
Senesco Raises USD3.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Senesco Raises USD5.4 Million in First Tranche of Private Placement of Units 22
Senesco Technologies Completes Private Placement Of Shares For US$1.7 Million 23
Senesco Technologies Completes Private Placement Of Shares For US$1.25 Million 24
Senesco Technologies Completes Private Placement Of Shares For US$3 Million 26
Senesco Technologies Completes Second Tranche Of Private Placement Of Shares For US$1 Million 28
Senesco Technologies Completes Second Tranche Of Private Placement For US$1.65 Million 30
Senesco Technologies Completes Private Placement Of US$11.5 Million 31
Acquisition 33
Senesco Technologies Completes Acquisition of Fabrus 33
Sevion Therapeutics, Inc. - Key Competitors 34
Key Employees 35
Locations And Subsidiaries 36
Head Office 36
Other Locations & Subsidiaries 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37
List of Tables
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Key Facts, 2015 1
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare Deals By Type, 2010 to YTD 2016 6
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sevion Therapeutics, Inc., Deals By Therapy Area, 2010 to YTD 2016 8
Sevion Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals Summary, 2010 to YTD 2016 10
Fabrus Secures US$2 Million In Venture Financing 12
Tetragenetics Enters into Agreement with arGEN-X, Crystal Biosciences and Sevion Therapeutics 13
Sevion Therapeutics to Form Joint Venture with Malvern Instruments 14
Sevion Therapeutics Enters into Discovery Agreement with CNA Development 15
Sevion Therapeutics Enters into Research Agreement with Avidity NanoMedicines 16
Fabrus Enters Into Research Agreement With Ambrx 17
Fabrus Enters into Licensing Agreement with Scripps Research Institute 18
Sevion Therapeutics Raises USD6.6 Million in Private Placement of Units 19
Senesco Raises USD3.5 Million in Private Placement of Shares upon Exercise of Warrants 21
Senesco Raises USD5.4 Million in First Tranche of Private Placement of Units 22
Senesco Technologies Completes Private Placement Of Shares For US$1.7 Million 23
Senesco Technologies Completes Private Placement Of Shares For US$1.25 Million 24
Senesco Technologies Completes Private Placement Of Shares For US$3 Million 26
Senesco Technologies Completes Second Tranche Of Private Placement Of Shares For US$1 Million 28
Senesco Technologies Completes Second Tranche Of Private Placement For US$1.65 Million 30
Senesco Technologies Completes Private Placement Of US$11.5 Million 31
Senesco Technologies Completes Acquisition of Fabrus 33
Sevion Therapeutics, Inc., Key Competitors 34
Sevion Therapeutics, Inc., Key Employees 35
Sevion Therapeutics, Inc., Subsidiaries 36
List of Figures
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 1
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 1
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 1
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 1
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016 5
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016 6
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Region, 2010 to YTD 2016 7
Sevion Therapeutics, Inc., Pharmaceuticals & Healthcare, Deals By Therapy Area, 2010 to YTD 2016 8
Sevion Therapeutics, Inc., Medical Devices Deals, 2010 to YTD 2016 9
